Novo Nordisk Clinical Trial Data Breach: Defending R&D and EPHI

Introduction

Novo Nordisk, a global pharmaceutical leader, recently disclosed a security breach involving the compromise of clinical trials data. This incident underscores the critical vulnerabilities in Life Sciences organizations where Research & Development (R&D) data intersects with Electronic Protected Health Information (ePHI). For defenders, this is not just a privacy notification; it is a signal that threat actors are actively targeting the intellectual property and patient data that drives modern medicine. The exposure of clinical trial data can lead to regulatory fallout (FDA/EMA/HIPAA), severe reputational damage, and long-term R&D sabotage. Immediate action is required to audit data egress controls and secure clinical trial management environments.

Technical Analysis

While the specific initial access vector in this specific disclosure is often the result of sophisticated supply chain compromises or credential theft in the healthcare sector, the impact is the unauthorized access to highly sensitive datasets.

Affected Assets: Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC) systems, and file repositories containing Subject Case Report Forms (CRFs).
Data at Risk: Patient PII/PHI, adverse event reports, and proprietary drug efficacy data.
Attack Chain (Observed in similar Pharma intrusions):
1. Initial Access: Phishing or compromised third-party credentials valid for VPN/Web portals.
2. Discovery: Enumeration of file shares and databases for keywords like "protocol," "blind," or "patient."
3. Staging & Exfiltration: Compression of large data sets (PDFs, CSVs, SAS datasets) into encrypted archives to bypass DLP filters, followed by exfiltration via cloud storage or custom command-and-control (C2) channels.

Exploitation Status: While no specific zero-day CVE (2025/2026) was cited in the immediate disclosure, the active theft of clinical data suggests the use of valid credentials and "living off the land" techniques, making traditional signature-based detection less effective.

Detection & Response

Detecting the theft of clinical data requires focusing on anomalies in data movement and access patterns rather than just known malicious binaries. The following rules are designed to catch the staging and exfiltration of proprietary clinical information.

SIGMA Rules

YAML

---
title: Potential Clinical Data Exfiltration via Archiving
id: 8a4f3c21-1b9d-4e7f-9a10-2d5c6e7f8a9b
status: experimental
description: Detects suspicious archive creation processes involving clinical trial file types or keywords often found in R&D environments.
references:
  - https://attack.mitre.org/techniques/T1560/001/
author: Security Arsenal
date: 2026/04/15
tags:
  - attack.exfiltration
  - attack.t1560.001
logsource:
  category: process_creation
  product: windows
detection:
  selection_archiver:
    Image|endswith:
      - '\7z.exe'
      - '\winrar.exe'
      - '\zip.exe'
  selection_cli:
    CommandLine|contains:
      - '-p'
      - '-mhe'
  selection_keywords:
    CommandLine|contains:
      - 'clinical'
      - 'trial'
      - 'patient'
      - ' blinded '
      - 'protocol'
  condition: selection_archiver and selection_cli and selection_keywords
falsepositives:
  - Legitimate backup operations by IT staff
level: high
---
title: Unusual Access to Clinical Trial Shares
id: 9b5e4d32-2c0e-5f8g-0b21-3e6d7f8g9h0c
status: experimental
description: Detects access patterns indicative of mass file enumeration or copying from sensitive R&D file shares.
references:
  - https://attack.mitre.org/techniques/T1005/
author: Security Arsenal
date: 2026/04/15
tags:
  - attack.collection
  - attack.t1005
logsource:
  category: file_access
  product: windows
detection:
  selection:
    TargetFilename|contains:
      - '\Clinical\'
      - '\R&D\'
      - '\Trials\'
  filter:
    Image|endswith:
      - '\explorer.exe'
      - '\winword.exe'
      - '\excel.exe'
  condition: selection and not filter
falsepositives:
  - Authorized researcher access
level: medium

KQL (Microsoft Sentinel / Defender)

KQL — Microsoft Sentinel / Defender

// Hunt for massive data egress related to clinical data archives
let FileExtensions = dynamic(['.zip', '.rar', '.7z', '.tgz']);
let ClinicalKeywords = dynamic(['clinical', 'trial', 'patient', 'novonordisk', 'study', 'protocol']);
DeviceFileEvents
| where Timestamp > ago(7d)
| where ActionType == "FileCreated"
| where FileName has_any (FileExtensions)
| where InitiatingProcessCommandLine has_any (ClinicalKeywords) or FolderPath has_any (ClinicalKeywords)
| project Timestamp, DeviceName, InitiatingProcessAccountName, InitiatingProcessCommandLine, FileName, FileSize
| order by Timestamp desc

Velociraptor VQL

VQL — Velociraptor

-- Hunt for encrypted archives in user directories and common download paths
SELECT FullPath, Size, Mtime, Mode
FROM glob(globs='/Users/*/Downloads/*.zip', '/Users/*/Documents/*.7z', '/tmp/*.rar')
WHERE Mtime > now() - 7d
  AND Size > 10000000
-- Ordering by most recently modified
ORDER BY Mtime DESC

Remediation Script (PowerShell)

PowerShell

# Audit Clinical Shares for Recent Encrypted Archives
# Run with Administrative privileges on File Servers

$ClinicalPaths = @("C:\Shares\Clinical", "D:\R\D\Trials")
$Days = 7
$Keywords = @("clinical", "trial", "patient")

Write-Host "Scanning for potential exfiltration artifacts..." -ForegroundColor Cyan

foreach ($Path in $ClinicalPaths) {
    if (Test-Path $Path) {
        Get-ChildItem -Path $Path -Recurse -Include *.zip,*.rar,*.7z -ErrorAction SilentlyContinue |
        Where-Object { $_.LastWriteTime -gt (Get-Date).AddDays(-$Days) } |
        ForEach-Object {
            $matchesKeyword = $false
            # Check filename/path for sensitive keywords
            foreach ($kw in $Keywords) {
                if ($_.FullName -like "*$kw*") { $matchesKeyword = $true; break }
            }
            
            if ($matchesKeyword) {
                Write-Host "[ALERT] Potential Exfil Archive Found: $($_.FullName)" -ForegroundColor Red
                Write-Host "       Size: $($_.Length) bytes | Modified: $($_.LastWriteTime) | User: $($_.GetAccessControl().Owner)"
            }
        }
    }
}

Write-Host "Scan Complete. Review alerts above." -ForegroundColor Green

Remediation

Identity Audit: Immediately force a password reset and MFA re-enrollment for all accounts with access to the compromised clinical trial systems. Review Active Directory logs for impossible travel logins.
Network Segmentation: Ensure Clinical Trial environments are strictly segmented from the general corporate network. Confirm that firewall rules restrict access to known clinical IP ranges only.
Data Loss Prevention (DLP): Update DLP policies to specifically fingerprint clinical trial document templates and block unauthorized encryption of these files (blocking .zip/.rar creation with passwords from non-approved endpoints).
Supply Chain Vetting: If the breach was linked to a third-party partner, suspend their data access privileges until a forensic review of their security posture is completed.
Preservation: Do not delete or alter logs on the affected CTMS or file servers. Clone the drives of potentially impacted workstations for forensic imaging.

Related Resources

Security Arsenal Healthcare Cybersecurity AlertMonitor Platform Book a SOC Assessment healthcare Intel Hub